|
Free limited access to DrugPatentWatch is available for accredited media
outlets.
You will be provided a monthly patent expiration newsletter, access to
monthly patent expirations, dynamic customizable graphs of patent and innovation
metrics, and the ability to search for details on individual drugs and
drug applicants.
Usage Guidelines
- You are free to use material from DrugPatentWatch in your
publication, provided you cite DrugPatentWatch as your source
Minimal citations: DrugPatentWatch.com or
http://www.DrugPatentWatch.com
- If listing monthly patent expirations, you must include the phrase
"Drugs
may be covered by multiple patents or regulatory protections"
- You may exclude columns from the patent expiration tables, but do
not change the column headers (e.g. drug applicants must be called
'applicants')
- Complimentary access to this section is provided for legitimate
press usage. Commercial use requires a paid subscription.
- Failure to abide by the above guidelines will result in revocation
of access and potential charge for commercial usage.
- Contact admin@DrugPatentWatch.com
with any questions.
|
To request media access, fill out the following form:
Freelancers should ask their assignment editors to submit
a memo describing the sponsoring publication and intended use to
admin@DrugPatentWatch.com
|
